HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.

AuthorsR E Drasga, S D Williams, L H Einhorn, R Birch
JournalCancer treatment reports (Cancer Treat Rep) Vol. 71 Issue 9 Pg. 863-4 (Sep 1987) ISSN: 0361-5960 [Print] United States
PMID3040247 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • iproplatin
Topics
  • Antineoplastic Agents (therapeutic use)
  • Drug Evaluation
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal (drug therapy)
  • Organoplatinum Compounds (therapeutic use)
  • Testicular Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: